ExploreWatchlistsPricing
  1. JP-listed companies
  2. GNI Group Ltd.
  3. Financials
  4. Net income

GNI Group Ltd. (2160)

Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 2025-4,244-486.44%
Dec 31, 20241,098-86.43%
Dec 31, 20238,094+1981.71%
Dec 31, 2022389-63.53%
Dec 31, 20211,066-15.26%
Dec 31, 20201,258+591.88%
Dec 31, 2019182-190.86%
Dec 31, 2018-200+14.23%
Dec 31, 2017-175-65.85%
Dec 31, 2016-513-17.66%
Dec 31, 2015-623+96.41%
Dec 31, 2014-317-56.58%
Dec 31, 2013-731+51.53%
Dec 31, 2012-482+10.75%
Dec 31, 2011-435

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat